Latin America PoC Infectious Disease Testing Market Size, Share & Trends Analysis Report By Type, By Disease, By End-use, By Country, And Segment Forecasts, 2024 - 2030

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Disease
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in Latin America
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type
  • 2.2.2. Disease
  • 2.2.3. End Use
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Latin America Point of Care (PoC) Infectious Disease Testing Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. High Disease Prevalence
    • 3.2.1.2. Technological Advancements
    • 3.2.1.3. Government and International Initiatives
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Limited Healthcare Access
    • 3.2.2.2. Regulatory and Approval Challenges
• 3.3. Latin America Point of Care (PoC) Infectious Disease Testing Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Estimates & Trend Analysis

• 4.1. Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Dashboard
• 4.2. Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Movement Analysis
• 4.3. Latin America Point of Care (PoC) Infectious Disease Testing Market by Type, Revenue
• 4.4. POC Rapid Diagnostic Single-test
  • 4.4.1. POC Rapid Diagnostic Single-test market estimates and forecasts, 2018 to 2030 (USD Million)
• 4.5. POC Rapid Diagnostic Combo-test
  • 4.5.1. POC Rapid Diagnostic Combo-test market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Estimates & Trend Analysis

• 5.1. Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Dashboard
• 5.2. Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Movement Analysis
• 5.3. Latin America Point of Care (PoC) Infectious Disease Testing Market Estimates and Forecasts, By Disease, Revenue (USD Million)
• 5.4. HIV POC
  • 5.4.1. HIV POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.5. Chlamydia & Gonorrhea
  • 5.5.1. Chlamydia & Gonorrhea only market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.6. Adenovirus
  • 5.6.1. Adenovirus market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.7. Rotavirus
  • 5.7.1. Rotavirus market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.8. Norovirus
  • 5.8.1. 5.5. Norovirus market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.9. Shigella
  • 5.9.1. Shigella market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.10. Dengue
  • 5.10.1. Dengue market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.11. Zika
  • 5.11.1. Zika market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.12. Typhoid
  • 5.12.1. Typhoid market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.13. Syphilis
  • 5.13.1. Syphilis market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.14. Malaria
  • 5.14.1. Malaria market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.15. Anti-TP (Treponema pallidum)
  • 5.15.1. Anti-TP (Treponema pallidum) market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.16. Monkeypox
  • 5.16.1. Monkeypox market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.17. Strep A
  • 5.17.1. Strep A market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.18. H. pylori
  • 5.18.1. H. pylori market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.19. HBV POC
  • 5.19.1. HBV POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.20. Pneumonia Or Streptococcus Associated Infections
  • 5.20.1. Pneumonia Or Streptococcus Associated Infections market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.21. Respiratory Syncytial Virus (RSV) POC
  • 5.21.1. Respiratory Syncytial Virus (RSV) POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.22. HPV POC
  • 5.22.1. HPV POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.23. Influenza/Flu POC
  • 5.23.1. Influenza/Flu POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.24. HCV POC
  • 5.24.1. HCV POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.25. MRSA POC
  • 5.25.1. MRSA POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.26. TB & Drug-resistant TB POC
  • 5.26.1. TB & Drug-resistant TB POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.27. HSV POC
  • 5.27.1. HSV POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.28. COVID-19
  • 5.28.1. COVID-19 POC market estimates and forecasts, 2018 to 2030 (USD Million)
• 5.29. Other Infectious Diseases
  • 5.29.1. Other Infectious Diseases POC market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Latin America Point of Care (PoC) Infectious Disease Testing Market: End Use Estimates & Trend Analysis

• 6.1. Latin America Point of Care (PoC) Infectious Disease Testing Market: Sales Indication Dashboard
• 6.2. Latin America Point of Care (PoC) Infectious Disease Testing Market: Sales Indication Movement Analysis
• 6.3. Latin America Point of Care (PoC) Infectious Disease Testing Market Estimates and Forecasts, By Sales Indication, Revenue (USD Million)
• 6.4. Clinics
  • 6.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.5. Hospitals
  • 6.5.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.6. Home
  • 6.6.1. Home market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.7. Assisted Living Healthcare Facilities
  • 6.7.1. Assisted Living Healthcare Facilities market estimates and forecasts, 2018 to 2030 (USD Million)
• 6.8. Laboratory
  • 6.8.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Latin America Point of Care (PoC) Infectious Disease Testing Market: Regional Estimates & Trend Analysis by Type, Disease, and End Use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. Latin America
  • 7.3.1. Brazil
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.3.2. Argentina
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.3.3. Rest of LATAM
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Regulatory framework/ reimbursement structure
    • 7.3.3.3. Competitive scenario
    • 7.3.3.4. Rest of LATAM market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
• 8.2. Vendor Landscape
  • 8.2.1. List of key distributors and channel partners
  • 8.2.2. Key company market share analysis, 2023
  • 8.2.3. InTec Products, Inc.
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Assure Tech (Hangzhou) Co., Ltd
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Getein Biotech, Inc.
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Xiamen Biotime Biotechnology Co., Ltd.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. Nantong Egens Biotechnology Co., Ltd.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Xiamen Boson Biotech Co., Ltd.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. F Hoffman-La Roche Ltd.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Abbott
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives
  • 8.2.11. Thermo Fisher Scientific, Inc.
    • 8.2.11.1. Company overview
    • 8.2.11.2. Financial performance
    • 8.2.11.3. Product benchmarking
    • 8.2.11.4. Strategic initiatives
  • 8.2.12. Siemens Healthcare AG
    • 8.2.12.1. Company overview
    • 8.2.12.2. Financial performance
    • 8.2.12.3. Product benchmarking
    • 8.2.12.4. Strategic initiatives
  • 8.2.13. Becton, Dickinson, and Company (BD)
    • 8.2.13.1. Company overview
    • 8.2.13.2. Financial performance
    • 8.2.13.3. Product benchmarking
    • 8.2.13.4. Strategic initiatives
  • 8.2.14. CTK Biotech
    • 8.2.14.1. Company overview
    • 8.2.14.2. Financial performance
    • 8.2.14.3. Product benchmarking
    • 8.2.14.4. Strategic initiatives

List of Tables

• Table 1 List Of Abbreviation
• Table 2 Latin America Point of Care (PoC) Infectious Disease Testing Market, By Region, 2018 - 2030 (USD Million)
• Table 3 Latin America Point of Care (PoC) Infectious Disease Testing Market, By Type, 2018 - 2030 (USD Million)
• Table 4 Latin America Point of Care (PoC) Infectious Disease Testing Market, By Disease, 2018 - 2030 (USD Million)
• Table 5 Latin America Point of Care (PoC) Infectious Disease Testing Market, By End Use, 2018 - 2030 (USD Million)
• Table 6 Brazil PoC Infectious Disease Testing Market, By Type, 2018 - 2030 (USD Million)
• Table 7 Brazil PoC Infectious Disease Testing Market, By Disease, 2018 - 2030 (USD Million)
• Table 8 Brazil PoC Infectious Disease Testing Market, By End Use, 2018 - 2030 (USD Million)
• Table 9 Argentina PoC Infectious Disease Testing Market, By Type, 2018 - 2030 (USD Million)
• Table 10 Argentina PoC Infectious Disease Testing Market, By Disease, 2018 - 2030 (USD Million)
• Table 11 Argentina PoC Infectious Disease Testing Market, By End Use, 2018 - 2030 (USD Million)
• Table 12 Rest of Latin America Point of Care (PoC) Infectious Disease Testing Market, By Type, 2018 - 2030 (USD Million)
• Table 13 Rest of Latin America Point of Care (PoC) Infectious Disease Testing Market, By Disease, 2018 - 2030 (USD Million)
• Table 14 Rest of Latin America Point of Care (PoC) Infectious Disease Testing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Primary interviews in North America
• Fig. 5 Primary interviews in Europe
• Fig. 6 Primary interviews in APAC
• Fig. 7 Primary interviews in Latin America
• Fig. 8 Primary interviews in MEA
• Fig. 9 Market research approaches
• Fig. 10 Value-chain-based sizing & forecasting
• Fig. 11 QFD modeling for market share assessment
• Fig. 12 Market formulation & validation
• Fig. 13 Latin America Point of Care (PoC) Infectious Disease Testing Market: Market Outlook
• Fig. 14 Latin America Point of Care (PoC) Infectious Disease Testing Competitive Insights
• Fig. 15 Parent market outlook
• Fig. 16 Related/ancillary market outlook
• Fig. 17 Latin America Point of Care (PoC) Infectious Disease Testing Market Driver Impact
• Fig. 18 Latin America Point of Care (PoC) Infectious Disease Testing Market Restraint Impact
• Fig. 19 Latin America Point of Care (PoC) Infectious Disease Testing Market Strategic Initiatives Analysis
• Fig. 20 Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Movement Analysis
• Fig. 21 Latin America Point of Care (PoC) Infectious Disease Testing Market: Type Outlook And Key Takeaways
• Fig. 22 POC rapid diagnostic single-test market estimates and forecast, 2018 - 2030
• Fig. 23 POC rapid diagnostic combo-test market estimates and forecast, 2018 - 2030
• Fig. 24 Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Movement Analysis
• Fig. 25 Latin America Point of Care (PoC) Infectious Disease Testing Market: Disease Outlook And Key Takeaways
• Fig. 26 HIV POC market estimates and forecast, 2018 - 2030
• Fig. 27 Chlamydia & gonorrhea market estimates and forecast, 2018 - 2030
• Fig. 28 Adenovirus market estimates and forecast, 2018 - 2030
• Fig. 29 Rotavirus market estimates and forecast, 2018 - 2030
• Fig. 30 Norovirus market estimates and forecast, 2018 - 2030
• Fig. 31 Shigella market estimates and forecast, 2018 - 2030
• Fig. 32 Dengue market estimates and forecast, 2018 - 2030
• Fig. 33 Zika market estimates and forecast, 2018 - 2030
• Fig. 34 Syphilis market estimates and forecast, 2018 - 2030
• Fig. 35 Malaria market estimates and forecast, 2018 - 2030
• Fig. 36 Anti-TP (Treponema pallidum) market estimates and forecast, 2018 - 2030
• Fig. 37 Monkeypox market estimates and forecast, 2018 - 2030
• Fig. 38 Strep A market estimates and forecast, 2018 - 2030
• Fig. 39 H. pylori market estimates and forecast, 2018 - 2030
• Fig. 40 HBV POC market estimates and forecast, 2018 - 2030
• Fig. 41 Pneumonia or streptococcus associated infections market estimates and forecast, 2018 - 2030
• Fig. 42 Respiratory Syncytial Virus (RSV) POC market estimates and forecast, 2018 - 2030
• Fig. 43 HPV POC market estimates and forecast, 2018 - 2030
• Fig. 44 Influenza/Flu POC market estimates and forecast, 2018 - 2030
• Fig. 45 HCV POC market estimates and forecast, 2018 - 2030
• Fig. 46 MRSA POC market estimates and forecast, 2018 - 2030
• Fig. 47 TB & Drug-resistant TB POC market estimates and forecast, 2018 - 2030
• Fig. 48 HSV POC market estimates and forecast, 2018 - 2030
• Fig. 49 COVID-19 market estimates and forecast, 2018 - 2030
• Fig. 50 Other Infectious Diseases market estimates and forecast, 2018 - 2030
• Fig. 51 Latin America Point of Care (PoC) Infectious Disease Testing Market: End Use Movement Analysis
• Fig. 52 Latin America Point of Care (PoC) Infectious Disease Testing Market: End Use Outlook And Key Takeaways
• Fig. 53 Clinics market estimates and forecast, 2018 - 2030
• Fig. 54 Hospitals market estimates and forecast, 2018 - 2030
• Fig. 55 Home market estimates and forecast, 2018 - 2030
• Fig. 56 Assisted Living Healthcare Facilities market estimates and forecast, 2018 - 2030
• Fig. 57 Laboratory market estimates and forecast, 2018 - 2030
• Fig. 58 LATAM market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Brazil key country dynamics
• Fig. 60 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Argentina key country dynamics
• Fig. 62 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Rest of LATAM key country dynamics
• Fig. 64 Rest of LATAM market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Market share of key market players - Pet insurance market